Home » Topics » BioWorld Science

BioWorld Science
RSS

CHMP adopts positive opinion for Yescarta

July 2, 2018

Phase II results presented from pivotal CAPTIVATE trial of ibrutinib plus venetoclax

July 2, 2018

Refixia obtain Japanese approval for the treatment of hemophilia B

July 2, 2018

Kymriah granted positive CHMP opinion for the treatment of two aggressive blood cancers

July 2, 2018

Patient enrollment ongoing in phase I/II study of SOBI-003 in pediatric MPS IIIA

July 2, 2018

First-in-human study of D-0502 is enrolling participants

July 2, 2018

Ocular Therapeutix announces NDA resubmission to the FDA for Dextenza

July 2, 2018

Laboratorios del Dr. Esteve presents new pyridazine derivatives for pain

July 2, 2018

Positive CHMP opinion granted for Mepsevii for the treatment of mucopolysaccharidosis VII

July 2, 2018

Cefepime/VNRX-5133 fixed-dose combination shows promise against resistant Gram-negative bacteria

July 2, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...